Medical Devices
-
Retrieved from Medtronic on June 23, 2026
Medtronic appoints veteran J&J exec as first CFO of innovation
Eric Lenard comes to the new position with more than two decades of experience in medtech finance, as Medtronic steps up its investment in innovation.
By Susan Kelly • June 23, 2026 -
Karl Storz laying off employees in North Carolina amid robotics strategy shift
The cuts come as Karl Storz plans to retire the Asensus brand and the Senhance robot as part of organizational changes.
By Susan Kelly • June 22, 2026 -
Explore the Trendline➔
Permission granted by Boston Scientific
TrendlineNew medical devices are reshaping the medtech industry
From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.
By MedTech Dive staff -
4 diabetes tech execs on the future of multi-analyte glucose sensors
Executives with Abbott, PercuSense and Biolinq spoke with MedTech Dive about what’s next with multi-analyte sensor technology.
By Elise Reuter • June 22, 2026 -
FDA posts early alert over device used with Impella heart pumps
J&J’s Abiomed and manufacturing partner Oscor warned of a bleeding risk from devices used to introduce catheters to the body.
By Nick Paul Taylor • June 22, 2026 -
Zoll receives FDA warning letter over quality concerns
The FDA cited problems with some of Zoll’s ventilators, automated external defibrillators and electrodes.
By Elise Reuter • Updated June 22, 2026 -
Penumbra wins CE mark for Thunderbolt clot removal tech
The international launch could benefit from Boston Scientific’s global footprint when the company closes its takeover of Penumbra.
By Nick Paul Taylor • June 18, 2026 -
Distalmotion, in US push, adds more robotic gynecology indications
The Swiss robotic surgery company, which is rolling out its Dexter system in the U.S., said the new indications will help ASCs maximize use of the system.
By Susan Kelly • June 17, 2026 -
Retrieved from Hologic on June 17, 2026
FDA warns breast biopsy needle shortage to continue into 2027
The shortage follows Hologic removing certain breast biopsy needles from the market in January.
By Elise Reuter • June 17, 2026 -
Medtech M&A maintains momentum following decade-high 2025: PwC
Deal volumes and values are tracking above the first half of 2025, driven by Boston Scientific’s Penumbra buyout and Danaher’s Masimo acquisition.
By Nick Paul Taylor • June 17, 2026 -
Profile
‘Putting the body back together’ with MMI’s microsurgery robot
MMI built a robot to help surgeons perform microsurgical procedures with more control than is possible with the human hand alone.
By Susan Kelly • June 17, 2026 -
J&J commits $1B to expand contact lens production in Florida
The investment will add J&J’s manufacturing, packaging and distribution capabilities to meet growing demand for its contact lenses.
By Nick Paul Taylor • June 16, 2026 -
CMS proposes Medicare coverage expansion for TAVR
The proposed Medicare coverage change could help Edwards Lifesciences gain market share from Medtronic and Boston Scientific, an analyst said.
By Susan Kelly • June 16, 2026 -
In a first, Dexcom’s OTC glucose sensor is cleared for kids
The Stelo over-the-counter glucose monitor can now be used by children as young as two years.
By Elise Reuter • June 15, 2026 -
Medtronic closes Scientia Vascular takeover, continuing M&A streak
CEO Geoff Martha said the acquisition will enable “every neurovascular procedure to start with Medtronic.”
By Nick Paul Taylor • June 15, 2026 -
Top medtech stories from ADA’s Scientific Sessions
Dexcom, Abbott, MiniMed and Insulet featured upcoming technologies at the American Diabetes Association’s annual event. Catch up on news coming out of the conference.
By Elise Reuter • June 12, 2026 -
Penumbra’s FDA nod for clot removal tech a win for Boston Scientific
The stroke treatment could contribute about $100 million in incremental revenue over time to Boston Scientific, the buyer of Penumbra, one analyst said.
By Susan Kelly • June 12, 2026 -
Why Insulet thinks its fully closed loop system will stand apart from rivals
Chief Medical Officer Trang Ly said the system, which allows people to manage Type 2 diabetes without bolusing, will be “completely different” than those being developed by MiniMed and Tandem Diabetes Care.
By Elise Reuter • June 11, 2026 -
Danaher closes $9.9B Masimo buyout
CEO Rainer Blair said Danaher has the money and “leadership bandwidth” to strike further deals across any of its three business areas.
By Nick Paul Taylor • June 11, 2026 -
GT Medical raises $100M for brain tumor tech after clinical trial success
Adoption of the GammaTile radiotherapy implant is growing, the company said, and the new funding round validates its potential to be a standard of care treatment.
By Susan Kelly • June 10, 2026 -
Bausch + Lomb to lay off employees in Missouri
The company plans to eliminate 119 positions by mid-December as part of a phased transfer of some production from the manufacturing site.
By Nick Paul Taylor • June 10, 2026 -
MiniMed is in the lead as diabetes tech firms focus on ‘fully closed loop’ systems, exec says
Ali Dianaty, MiniMed’s chief product and technology officer, believes the company is “clearly ahead” of the competition in developing automated insulin delivery systems that don’t require meal announcements.
By Elise Reuter • June 9, 2026 -
Medtronic set for Stealth AXiS expansion in Europe
With the CE mark for ear, nose and throat procedures, the advanced surgical navigation platform will be available to more surgeons across the region.
By Susan Kelly • June 9, 2026 -
Dexcom bolsters evidence for glucose sensors for Type 2 diabetes
New study results could lead to better insurance coverage of the devices for people who don’t take insulin, a researcher said.
By Elise Reuter • June 9, 2026 -
Medtronic gets FDA nod for updated pulse oximetry system
The changes support accuracy across diverse patient populations, skin tones and clinical care settings.
By Nick Paul Taylor • June 9, 2026 -
3 takeaways from ADA
Tandem Diabetes Care, Insulet and Dexcom all presented data over the weekend at the American Diabetes Association’s Scientific Sessions.
By Elise Reuter • June 8, 2026